-+ 0.00%
-+ 0.00%
-+ 0.00%

Pluri Subsidiary Puri Biotech Secures Patent Covering 3D Immune Cell Expansion Tech

Benzinga·02/18/2026 13:03:44
Listen to the news

The China National Intellectual Property Administration (CNIPA) has granted Pluri Biotech Ltd., a wholly owned subsidiary of Pluri, a patent covering its proprietary 3D immune cell expansion and activation technology.